Cargando…
Case report of two affected siblings in a family with thiamine metabolism dysfunction syndrome 5: a rare, but treatable neurodegenerative disease
BACKGROUND: Thiamine metabolism dysfunction syndrome 5 (THMD5) is a rare inherited metabolic disorder due to thiamine pyrophosphokinase 1(TPK1) deficiency, caused by mutations in TPK1. The core symptoms of the disease is acute or subacute onset encephalopathy, ataxia, muscle hypotonia, and regressio...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520874/ https://www.ncbi.nlm.nih.gov/pubmed/36175994 http://dx.doi.org/10.1186/s12883-022-02887-9 |
_version_ | 1784799722307846144 |
---|---|
author | Li, Xiaoyan Huang, Zhixin Chen, Yong Sun, Xiaolan Yi, Zhaoshi Xie, Jihua Yu, Xiongying Chen, Hui Zhong, Jianmin |
author_facet | Li, Xiaoyan Huang, Zhixin Chen, Yong Sun, Xiaolan Yi, Zhaoshi Xie, Jihua Yu, Xiongying Chen, Hui Zhong, Jianmin |
author_sort | Li, Xiaoyan |
collection | PubMed |
description | BACKGROUND: Thiamine metabolism dysfunction syndrome 5 (THMD5) is a rare inherited metabolic disorder due to thiamine pyrophosphokinase 1(TPK1) deficiency, caused by mutations in TPK1. The core symptoms of the disease is acute or subacute onset encephalopathy, ataxia, muscle hypotonia, and regression of developmental milestones in early infancy, repeatedly triggered by acute infectious illness. However, we report two brothers of THMD5 with compound heterozygous for the mutations c.614-1G > A,c.224 T > A p.(Ile75Asn), but the prognosis is quite different if thiamine suppled. According to our current knowledge, the missense variant c.224 T > A p.(Ile75Asn) was not published previously. CASE PRESENTATION: Here, we describe two affected siblings in a Chinese family, after an uneventful pregnancy to non-consanguineous and healthy parents. The older brother presented with normal development during the first 6 months of life, but developed regression of developmental milestones after, accompanied with muscle hypotonia, and chronic encephalopathy, and died at 1 year and 6 months old. The younger brother presented with acute onset encephalopathy, ataxia, muscle hypotonia, repeatedly triggered by acute infectious illness. He was compound heterozygous for the mutations c.614-1G > A,c.224 T > A p.(Ile75Asn) identified by whole exome sequencing. He was diagnosed of THMD5 when he was 11 month. Oral supplementation of thiamine 100 mg/day, the symptoms gradually disappeared. At the age of 2 years and 4 months, he stoped thiamine, his symptoms returned and were once again relieved by oral supplementation of thiamine 100 mg/day. CONCLUSIONS: THMD5 is a rare, but treatable neurodegenerative disease, the clinical phenotype ranges from mild to severe. Massive-dose of thiamine supplementation may ameliorate the course of TPK1 deficiency. When similar clinical cases appear, gene detection is particularly important, which is conducive to early diagnosis. Treatment with thiamine while awaiting the outcome of diagnostic tests may be a good choice. |
format | Online Article Text |
id | pubmed-9520874 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-95208742022-09-30 Case report of two affected siblings in a family with thiamine metabolism dysfunction syndrome 5: a rare, but treatable neurodegenerative disease Li, Xiaoyan Huang, Zhixin Chen, Yong Sun, Xiaolan Yi, Zhaoshi Xie, Jihua Yu, Xiongying Chen, Hui Zhong, Jianmin BMC Neurol Case Report BACKGROUND: Thiamine metabolism dysfunction syndrome 5 (THMD5) is a rare inherited metabolic disorder due to thiamine pyrophosphokinase 1(TPK1) deficiency, caused by mutations in TPK1. The core symptoms of the disease is acute or subacute onset encephalopathy, ataxia, muscle hypotonia, and regression of developmental milestones in early infancy, repeatedly triggered by acute infectious illness. However, we report two brothers of THMD5 with compound heterozygous for the mutations c.614-1G > A,c.224 T > A p.(Ile75Asn), but the prognosis is quite different if thiamine suppled. According to our current knowledge, the missense variant c.224 T > A p.(Ile75Asn) was not published previously. CASE PRESENTATION: Here, we describe two affected siblings in a Chinese family, after an uneventful pregnancy to non-consanguineous and healthy parents. The older brother presented with normal development during the first 6 months of life, but developed regression of developmental milestones after, accompanied with muscle hypotonia, and chronic encephalopathy, and died at 1 year and 6 months old. The younger brother presented with acute onset encephalopathy, ataxia, muscle hypotonia, repeatedly triggered by acute infectious illness. He was compound heterozygous for the mutations c.614-1G > A,c.224 T > A p.(Ile75Asn) identified by whole exome sequencing. He was diagnosed of THMD5 when he was 11 month. Oral supplementation of thiamine 100 mg/day, the symptoms gradually disappeared. At the age of 2 years and 4 months, he stoped thiamine, his symptoms returned and were once again relieved by oral supplementation of thiamine 100 mg/day. CONCLUSIONS: THMD5 is a rare, but treatable neurodegenerative disease, the clinical phenotype ranges from mild to severe. Massive-dose of thiamine supplementation may ameliorate the course of TPK1 deficiency. When similar clinical cases appear, gene detection is particularly important, which is conducive to early diagnosis. Treatment with thiamine while awaiting the outcome of diagnostic tests may be a good choice. BioMed Central 2022-09-29 /pmc/articles/PMC9520874/ /pubmed/36175994 http://dx.doi.org/10.1186/s12883-022-02887-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Case Report Li, Xiaoyan Huang, Zhixin Chen, Yong Sun, Xiaolan Yi, Zhaoshi Xie, Jihua Yu, Xiongying Chen, Hui Zhong, Jianmin Case report of two affected siblings in a family with thiamine metabolism dysfunction syndrome 5: a rare, but treatable neurodegenerative disease |
title | Case report of two affected siblings in a family with thiamine metabolism dysfunction syndrome 5: a rare, but treatable neurodegenerative disease |
title_full | Case report of two affected siblings in a family with thiamine metabolism dysfunction syndrome 5: a rare, but treatable neurodegenerative disease |
title_fullStr | Case report of two affected siblings in a family with thiamine metabolism dysfunction syndrome 5: a rare, but treatable neurodegenerative disease |
title_full_unstemmed | Case report of two affected siblings in a family with thiamine metabolism dysfunction syndrome 5: a rare, but treatable neurodegenerative disease |
title_short | Case report of two affected siblings in a family with thiamine metabolism dysfunction syndrome 5: a rare, but treatable neurodegenerative disease |
title_sort | case report of two affected siblings in a family with thiamine metabolism dysfunction syndrome 5: a rare, but treatable neurodegenerative disease |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520874/ https://www.ncbi.nlm.nih.gov/pubmed/36175994 http://dx.doi.org/10.1186/s12883-022-02887-9 |
work_keys_str_mv | AT lixiaoyan casereportoftwoaffectedsiblingsinafamilywiththiaminemetabolismdysfunctionsyndrome5ararebuttreatableneurodegenerativedisease AT huangzhixin casereportoftwoaffectedsiblingsinafamilywiththiaminemetabolismdysfunctionsyndrome5ararebuttreatableneurodegenerativedisease AT chenyong casereportoftwoaffectedsiblingsinafamilywiththiaminemetabolismdysfunctionsyndrome5ararebuttreatableneurodegenerativedisease AT sunxiaolan casereportoftwoaffectedsiblingsinafamilywiththiaminemetabolismdysfunctionsyndrome5ararebuttreatableneurodegenerativedisease AT yizhaoshi casereportoftwoaffectedsiblingsinafamilywiththiaminemetabolismdysfunctionsyndrome5ararebuttreatableneurodegenerativedisease AT xiejihua casereportoftwoaffectedsiblingsinafamilywiththiaminemetabolismdysfunctionsyndrome5ararebuttreatableneurodegenerativedisease AT yuxiongying casereportoftwoaffectedsiblingsinafamilywiththiaminemetabolismdysfunctionsyndrome5ararebuttreatableneurodegenerativedisease AT chenhui casereportoftwoaffectedsiblingsinafamilywiththiaminemetabolismdysfunctionsyndrome5ararebuttreatableneurodegenerativedisease AT zhongjianmin casereportoftwoaffectedsiblingsinafamilywiththiaminemetabolismdysfunctionsyndrome5ararebuttreatableneurodegenerativedisease |